According to the CITIC Construction Investment Securities Research Report, at present, the AI pharmaceutical industry chain has evolved into a network enabling system with platforms and technology centers as the core, deep collaboration between the upper, middle, and lower levels, and is showing a development trend where various business models are compatible. AI4S is moving from a model capability competition to a tipping point of industrialization. The quadruple resonance of technology, industry, demand, and policy resonates, and the value anchor is upgraded from model capability to scientific research productivity, data assets, and systematic biological design.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.